Investing in life science companies is challenging as the pace of progression in life science and biotech innovation is progressing exponentially, with exciting breakthrough products and technologies revolutionising the diagnosis, management, and treatment of diseases. However, even the very innovative companies in this space must work hard to attract investment and, despite the significant sums of capital that flow into the sector, there are many segments of the market that … Continue reading →